Literature DB >> 10782699

Dynamics and control of the global tuberculosis epidemic.

D Bleed1, C Dye, M C Raviglione.   

Abstract

Studies of disease burden have reaffirmed that tuberculosis is among the top 10 causes of death in the world. The tuberculosis epidemic in most countries could eventually be brought under control by implementing the World Health Organization's (WHO) directly observed therapy, short course (DOTS) strategy, although tuberculosis linked to human immunodeficiency virus (HIV) in Africa and multidrug-resistant tuberculosis (MDR-TB) in the former Soviet Union urgently demand adaptations and extensions of DOTS. Most high-incidence countries have achieved treatment success rates approaching the WHO 85% target in pilot projects. In the long term, we may have better diagnostics, drugs, and vaccines to control the disease; for the next 5 years, the central problem in global tuberculosis control is to expand DOTS coverage in high-incidence countries. Improved case finding and diagnosis, coupled with best-practice short-course chemotherapy, could quickly and dramatically cut the number of years of healthy life lost due to tuberculosis, especially by preventing death.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10782699     DOI: 10.1097/00063198-200005000-00002

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  11 in total

1.  Ipr1 gene mediates innate immunity to tuberculosis.

Authors:  Hui Pan; Bo-Shiun Yan; Mauricio Rojas; Yuriy V Shebzukhov; Hongwei Zhou; Lester Kobzik; Darren E Higgins; Mark J Daly; Barry R Bloom; Igor Kramnik
Journal:  Nature       Date:  2005-04-07       Impact factor: 49.962

2.  Imatinib-sensitive tyrosine kinases regulate mycobacterial pathogenesis and represent therapeutic targets against tuberculosis.

Authors:  Ruth J Napier; Wasiulla Rafi; Mani Cheruvu; Kimberly R Powell; M Analise Zaunbrecher; William Bornmann; Padmini Salgame; Thomas M Shinnick; Daniel Kalman
Journal:  Cell Host Microbe       Date:  2011-11-17       Impact factor: 21.023

3.  Murine model of BCG lung infection: dynamics of lymphocyte subpopulations in lung interstitium and tracheal lymph nodes.

Authors:  Rajiv K Saxena; David Weissman; Janet Simpson; Daniel M Lewis
Journal:  J Biosci       Date:  2002-03       Impact factor: 1.826

Review 4.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 5.  To control and beyond: moving towards eliminating the global tuberculosis threat.

Authors:  Timothy F Brewer; S Jody Heymann
Journal:  J Epidemiol Community Health       Date:  2004-10       Impact factor: 3.710

6.  Kinetics of changes in lymphocyte sub-populations in mouse lungs after intrapulmonary infection with M. bovis (Bacillus Calmette-Guerin) and identity of cells responsible for IFNgamma responses.

Authors:  R K Saxena; D Weissman; Q B Saxena; J Simpson; D M Lewis
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

7.  Genotypic diversity and drug susceptibility patterns among M. tuberculosis complex isolates from South-Western Ghana.

Authors:  Dorothy Yeboah-Manu; Adwoa Asante-Poku; Thomas Bodmer; David Stucki; Kwadwo Koram; Frank Bonsu; Gerd Pluschke; Sebastien Gagneux
Journal:  PLoS One       Date:  2011-07-11       Impact factor: 3.240

8.  Prioritising between direct observation of therapy and case-finding interventions for tuberculosis: use of population impact measures.

Authors:  Richard F Heller; Islay Gemmell; Richard Edwards; Iain Buchan; Shally Awasthi; James A Volmink
Journal:  BMC Med       Date:  2006-12-20       Impact factor: 8.775

9.  Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001.

Authors:  Abraham Miranda; Meade Morgan; Leda Jamal; Kayla Laserson; Draurio Barreira; Guida Silva; Joseney Santos; Charles Wells; Patricia Paine; Denise Garrett
Journal:  PLoS One       Date:  2007-09-05       Impact factor: 3.240

10.  Strain diversity of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Afar pastoral region of Ethiopia.

Authors:  Mulugeta Belay; Gobena Ameni; Gunnar Bjune; David Couvin; Nalin Rastogi; Fekadu Abebe
Journal:  Biomed Res Int       Date:  2014-03-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.